Soo Jung Lee, MD
Psychiatry · Pasadena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Pacific Clinics · 72 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office at (626) 403-2794 to ask if they take your plan before you enroll.
California Medical Board record
Licence A123814 · Current
Licensed to practise in California · since 2012 · expires 2028-09-30 · American University of the Caribbean School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036132556Licensed Physician And Surgeon · since 2013 · expires 2029-07-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$2,159 in 2018
Medicaid paid $2,159 for 72 billed services this clinician did in 2018, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 72 | $2,159 |
| 2018 | 72 | 1 | 24 | $2,159 |
Drugs they prescribed that Part D paid
$44
Pharmacies billed $44 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 24) in 2024. Too few prescriptions to compare fairly with other clinicians.
24 generic and 0 brand-name prescriptions · $44 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Escitalopram | 24 | $44 | $2 |
Year by year
| 2024 | 24 | None | 0% (0) | 0% | $44 |
| 2023 | 27 | None | 0% (0) | 0% | $289 |
| 2022 | 111 | None | 0% (0) | 11% | $20,846 |
| 2021 | 147 | 11 | 0% (0) | 8% | $19,117 |
| 2020 | 121 | 13 | 0% (0) | None | $10,452 |
| 2019 | 120 | None | 0% (0) | None | $19,357 |
| 2018 | 217 | None | 0% (0) | 0% | $24,325 |
| 2017 | 34 | None | 0% (0) | None | $1,664 |
| 2016 | 21 | None | 0% (0) | None | $218 |
| 2014 | 14 | None | 0% (0) | None | $5,372 |
| 2013 | 453 | 43 | None | 23% | $74,745 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Escitalopram | 26 | $282 | $11 |
2022: 5 drugs
| Vraylar | 11 | $15,528 | $1,412 |
| Sertraline | 37 | $245 | $7 |
| Lithium Carbonate Er | 11 | $227 | $21 |
| Escitalopram | 17 | $194 | $11 |
| Clonidine | 11 | $60 | $5 |
2021: 5 drugs
| Vraylar | 12 | $16,543 | $1,379 |
| Dextroamphetamine-Amphet Er | 13 | $343 | $26 |
| Sertraline | 40 | $254 | $6 |
| Diazepam | 12 | $66 | $5 |
| Clonidine | 12 | $65 | $5 |
2020: 5 drugs
| Lithium Carbonate Er | 11 | $442 | $40 |
| Sertraline | 17 | $295 | $17 |
| Dextroamphetamine-Amphet Er | 14 | $293 | $21 |
| Diazepam | 17 | $174 | $10 |
| Aripiprazole | 15 | $61 | $4 |
2019: 5 drugs
| Lithium Carbonate Er | 13 | $694 | $53 |
| Sertraline | 37 | $357 | $10 |
| Benztropine Mesylate | 15 | $235 | $16 |
| Diazepam | 11 | $117 | $11 |
| Clonidine | 11 | $88 | $8 |
2018: 8 drugs
| Paliperidone Er | 13 | $21,361 | $1,643 |
| Clozapine | 26 | $803 | $31 |
| Lithium Carbonate Er | 34 | $626 | $18 |
| Clonidine | 31 | $344 | $11 |
| Sertraline | 30 | $209 | $7 |
| Propranolol | 13 | $196 | $15 |
| Buspirone | 13 | $139 | $11 |
| Diazepam | 12 | $85 | $7 |
2017: 2 drugs
| Clonidine | 15 | $190 | $13 |
| Sertraline | 13 | $81 | $6 |
2013: 15 drugs
| Abilify | 27 | $23,472 | $869 |
| Risperdal Consta | 27 | $17,385 | $644 |
| Quetiapine | 31 | $11,867 | $383 |
| Cymbalta | 25 | $5,701 | $228 |
| Zolpidem Tartrate Er | 12 | $1,319 | $110 |
| Risperidone | 19 | $550 | $29 |
| Bupropion Xl | 12 | $501 | $42 |
| Clonazepam | 52 | $400 | $8 |
| Paroxetine | 11 | $340 | $31 |
| Trazodone | 47 | $247 | $5 |
| Fluoxetine | 16 | $219 | $14 |
| Benztropine Mesylate | 12 | $167 | $14 |
| Citalopram Hbr | 23 | $153 | $7 |
| Sertraline | 18 | $127 | $7 |
| Zolpidem | 15 | $79 | $5 |
Money from drug and device companies
$43 in 2021
| 2021 | 2 | 2 | None | $43 |
| 2020 | 8 | 12 | None | $183 |
| 2019 | 14 | 24 | None | $419 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Lundbeck | Meals · 2021-07-22 | Brintellix | $18 |
| AbbVie | Meals · 2021-04-08 | Vraylar | $26 |
See earlier years (2020, 2019)
2020: $183
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $58 | 3 payments
|
| Neos Therapeutics LP | Adzenys Xr-Odt | $32 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $27 | 1 payment
|
| OWP Pharmaceuticals | Subvenite | $16 | 2 payments
|
| Allergan | Vraylar | $14 | 1 payment
|
| Bausch Health US | Wellbutrin | $13 | 1 payment
|
| Alfasigma USA | None | $12 | 1 payment
|
| Lundbeck | Rexulti | $12 | 1 payment
|
2019: $419
| Allergan | Vraylar | $56 | 3 payments
|
| Tris Pharma | Quillivant Xr | $54 | 3 payments
|
| Shire North American Group | Vyvanse | $44 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $42 | 2 payments
|
| Janssen Pharmaceuticals | Spravato | $41 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $33 | 2 payments
|
| Neos Therapeutics LP | Adzenys Xr-Odt | $30 | 2 payments
|
| Vertical Pharmaceuticals | Relexxii | $23 | 1 payment
|
| Lundbeck | Rexulti | $18 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm 20mg Capsules (Bottle of 100) | $18 | 1 payment
|
| Rhodes Pharmaceuticals L.P. | Aptensio Xr | $16 | 1 payment
|
| Bausch Health US | Aplenzin | $16 | 1 payment
|
| Adlon Therapeutics L.P. | Adhansia Xr | $15 | 1 payment
|
| OWP Pharmaceuticals | Subvenite | $14 | 1 payment
|
Professional record
- NPI
- 1295046498
- Licence
- CA A123814, IL 036-132556California A123814: Current · expires 2028-09-30Illinois 036132556: Active
- Group
- Pacific Clinics
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 937 Genesee Dr, Naperville, IL, 60563
- NPI first listed
- 2010-06-23
- NPI last updated
- 2022-01-13
- NPI record certified
- 2022-01-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 251 Llewellyn Ave, Campbell, CA, 95008 · 5950 Lincoln Ave Ste W, Lisle, IL, 60532 · 100 Oak St Rm F-3, San Jose, CA, 95110